177 related articles for article (PubMed ID: 17378147)
1. [Optimal use of peritoneal dialysis fluids in type 2 diabetes mellitus patients].
Ryckelynck JP; Allard C; Cousin M; Hurault de Ligny B; El Haggan W; Lobbedez T
Nephrol Ther; 2006 Jan; 2 Suppl 1():S82-5. PubMed ID: 17378147
[TBL] [Abstract][Full Text] [Related]
2. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis].
Haag-Weber M
Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339
[TBL] [Abstract][Full Text] [Related]
3. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
[TBL] [Abstract][Full Text] [Related]
4. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
Higuchi C; Nishimura H; Sanaka T
Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
[TBL] [Abstract][Full Text] [Related]
5. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of peritoneal dialysis solutions in the mesenteric microcirculation.
Frajewicki V; Brod V; Kushnir D; Kohan R; Bitterman H
Transl Res; 2009 May; 153(5):249-56. PubMed ID: 19375686
[TBL] [Abstract][Full Text] [Related]
7. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
Bazargani F
Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
[TBL] [Abstract][Full Text] [Related]
8. Biocompatible peritoneal dialysis solutions: do we have one?
Chaudhary K; Khanna R
Clin J Am Soc Nephrol; 2010 Apr; 5(4):723-32. PubMed ID: 20093342
[TBL] [Abstract][Full Text] [Related]
9. [Peritoneal dialysis in patients with diabetic nephropathy].
Auinger M; Edlinger R; Prager R
Wien Klin Wochenschr; 2005; 117 Suppl 6():29-34. PubMed ID: 16437330
[TBL] [Abstract][Full Text] [Related]
10. [Specific aspects of peritoneal dialysis in diabetic patients].
Opatrná S; Klaboch J
Vnitr Lek; 2008 May; 54(5):523-9. PubMed ID: 18630640
[TBL] [Abstract][Full Text] [Related]
11. Management of patients with type 2 diabetes on peritoneal dialysis.
Dasgupta MK
Adv Perit Dial; 2005; 21():120-2. PubMed ID: 16686300
[TBL] [Abstract][Full Text] [Related]
12. [Sodium kinetics in peritoneal dialysis: from theory to clinical practice].
La Milia V
G Ital Nefrol; 2006; 23(1):37-48. PubMed ID: 16521074
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD.
Zareie M; Tangelder GJ; ter Wee PM; Hekking LH; van Lambalgen AA; Keuning ED; Schadee-Eestermans IL; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2005 Dec; 20(12):2783-92. PubMed ID: 16204296
[TBL] [Abstract][Full Text] [Related]
14. Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy.
Nakao A; Nakao K; Takatori Y; Kojo S; Inoue J; Akagi S; Sugiyama H; Wada J; Makino H
Nephrol Dial Transplant; 2010 May; 25(5):1479-88. PubMed ID: 19759273
[TBL] [Abstract][Full Text] [Related]
15. Glucotoxicity in peritoneal dialysis--solutions for the solution!
Holmes CJ
Adv Chronic Kidney Dis; 2007 Jul; 14(3):269-78. PubMed ID: 17603981
[TBL] [Abstract][Full Text] [Related]
16. [Peritoneal dialysis in patients with diabetes mellitus].
Plum J
Dtsch Med Wochenschr; 2005 Sep; 130(36):2035-8. PubMed ID: 16143936
[No Abstract] [Full Text] [Related]
17. Effects of glucose-free dialysis solutions on human peritoneal mesothelial cells.
Chang JM; Lin SP; Lai YH; Chen HC
Am J Nephrol; 2007; 27(2):206-11. PubMed ID: 17377374
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal defence--lessons learned which apply to diabetes complications.
Santamaría B; Sanz A; Justo P; Catalán M; Sánchez-Niño MD; Benito A; Lorz C; Marrón B; Ortiz A
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii12-5. PubMed ID: 16825252
[TBL] [Abstract][Full Text] [Related]
19. Biocompatibility of new peritoneal dialysis solutions: clinical experience.
Garcia-Lopez E; Lindholm B; Tranaeus A
Perit Dial Int; 2000; 20 Suppl 5():S48-56. PubMed ID: 11229612
[TBL] [Abstract][Full Text] [Related]
20. Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome.
Lee HY; Choi HY; Park HC; Seo BJ; Do JY; Yun SR; Song HY; Kim YH; Kim YL; Kim DJ; Kim YS; Kim MJ; Shin SK
Nephrol Dial Transplant; 2006 Oct; 21(10):2893-9. PubMed ID: 16957012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
